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SUMMARY 
We have synthesized the fluorine-I 8 labeled derivative of N-fert-butyl-a- 
phenylnitrone (PBN), a free radical spin trapping agent widely used with 
electron spin resonance (ESR). N-tert-Butyl-a-(4-[18F]fluorophenyl)- 
nitrone ([18F]FPBN) could be prepared with low radiochemical yield (3% 
decay corrected) by the direct aromatic nucleophilic substitution of N-tert- 
butyl-a-(4-nitrophenyl)nitrone with [18F]fluoride. An alternate two step 
synthesis route consisted of the nucleophilic [18F]fluoride substitution of 
4-N,N,N-trimethylammoniumbenzaldehyde triflate to yield 4-[18F]fluoro- 
benzaldehyde, which was distilled into a vial containing N-tert-butyl- 
hydroxylamine in 2N NaOH. 4-[18F]Fluorobenzaldehyde readily reacted 
with the hydroxylamine to form [IBFIFPBN . [18F]FPBN was obtained in 
overall decay corrected yields of 24% in a total synthesis time c45 min. 
and was suitable for further applications in in vivo studies of free 
radicals. 
Key-words: free radicals, PBN, fluorine-18, 4-[18F]fluoro- 
benzaldehyde 
INTRODUCTION 
The role of free radicals related to the pathology of various diseases and aging 
has gained increasing attention during the last decade. Ischemia-reperfusion injuries, 
neurodegenerative diseases, cigarette smoke toxicity and inflammation are among the 
fast growing list of disorders that are linked to the presence of free radicals in cells and 
tissues. A recent issue of the British Medical Bulletin extensively reviewed the 
relationship of free radicals and disease (1). 
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The presence of free radicals can be detected by electron spin resonance 
spectroscopy (ESR) but direct detection in tissue is difficult due to the short half-life 
and the low concentrations of free radicals. Free radicals can however be reacted in 
vivo with spin-trapping agents to form a relatively stable adduct that can be extracted 
from the homogenized tissue to be finally assayed by ESR. Direct in vivo ESR 
measurements of free radicals adducts have been reported but provide only limited 
spatial information (2-4). Another approach for the in vivo detection of free radicals is 
the observation of brain chemiluminesence accompanying the production of free 
radicals (5).  This method is however relatively invasive as it requires a cranial window 
and moreover does not provide any spatial information. 
Positron emission tomography (PET) with an appropriate radiopharmaceutical 
that binds to free radicals or their secondary products would be a valuable tool for the 
in vivo visualization and quantification of free radicals and the evaluation of drugs 
designed to scavenge free radicals. N-tert-Butyl-a-phenylnitrone (PBN, Fig. 1) forms 
adducts with free radicals (6) that can be detected by ESR and is frequently used for 
spin trapping studies. 
Fig. 1 Structure of N-teri-butyl-a-phenylnitrone (PBN), N-teri-butyl-a-(4-fluorophenyl)nitrone (FPBN), 
N-tert-butyl-a-(4-hydroxy-3-iodophenyl)nitrone (HIPBN) and the formation of a PBN radical 
adduct 
In animal experiments, PBN moreover appears to have neuroprotective (7), 
cardioprotective (8) and anti-aging (9) characteristics that are attributed to its free- 
radical scavenging abilities. Biodistribution studies in mice with [14C]PBN (10) 
indicate that this molecule is evenly distributed in various tissues including heart and 
brain. Wada et al. (1 1) have recently synthesized a radioiodinated derivative of PBN 
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(1251-HIPBN, Fig. 1) to pursue the detection of free radicals with single photon 
emission tomography (SPECT). 
In view of the appealing characteristics of PBN we have synthesized the 
fluorine-I8 labeled derivative N-tert-butyl-a-(4-[~~F]fluorophenyl)nitrone ([18F]FPBN, 
Fig. 1) in order to investigate the possibility of detecting free radicals in vivo with PET. 
METHODS AND MATERIALS 
N-tert-Butyl-cl-(4-nitrophenyl)nitrone, N-tert-butyl-a-phenylnitrone, N-terf- 
butylhydroxylamine hydrochloride, 4-fluorobenzaldehyde and Kryptofix 2.2.2. were 
commercially obtained from Aldrich Chem. Co (Milwaukee, MI). 4-N, N,N- 
Trimethylammoniumbenzaldehyde trifluoromethanesulfonate was synthesized 
according to the procedure published by Haka et al. (12). NMR spectra were acquired 
on a Bruker 300 NMR spectrometer. High resolution mass spectra were recorded on a 
VG 70-250s spectrometer. ['8F]Fluoride was produced by proton irradiation of 10% 
enrichment "801water (Swann Chem. Inc., Port Chester NY) using a TCC CS30 
cyclotron. The contents of the target were passed over an ion exchange column (Toray 
TIN-200 quartenary ammonium, carbonate form, 1.6 mm x 20 mm) to trap the 
[18F]fluoride and to recover the [18O]water. [18F]Fluoride was eluted from the column 
with 2.3 mg K2CO3 dissolved in 500 pI H20. The aqueous solution was used after a 
waiting period of 1 hour to allow the decay of 13N formed by the (p,a) reaction on 
natural water. 
HPLC analyses were performed on a 250x4.6mm Ultremex 5p C18 
(Phenomenex, Torrance CA) column eluted with CH3CN:H20 (50:50) at a flowrate of 
1.5 ml/min. (10). UV absorption was detected at 289 nm. The retention time in this 
system of the different compounds is presented in Table 1. Recovery of the 
radioactivity of a [18F]FPBN preparation from the HPLC column was 103+4% 
(meanrtsd, n=3), as determined by measurement of radioactivity in the total HPLC 
Table 1. HPLC retention time of different benzaldehydes and nitrones 
Compound Retention time (min.) 
4-NO2-benzaldehyde 4.78 
PBN 3.90 
FPBN 4.24 
N02PBN 5.45 
4-fluorobenzaldehyde 4.74 
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eluent after injection of an equal volume of [18F]FPBN solution, with and without the 
H P L C  column connected. A series of concentrations of authentic FPBN was used to 
construct a calibration curve for the determination of the specific activity. 
N-fetf-Bufyl-a-(4-fluorophenyl)nitrone (FPBN). 
N-ferf-Butylhydroxylamine.HC1 (225 mg, 1.8 mmol) was dissolved in 5 ml NaOH 
0.5N and heated in a water bath to 60OC. 4-Fluorobenzaldehyde (210 mg, 1.7 mmol) 
dissolved in 5 ml ethanol was added drop by drop to this solution over a period of 5 
min. The reaction mixture was stirred for 3 hours at 60OC to yield a yellow solution that 
was evaporated. Diethylether (15 ml) was added to the remaining oil, yielding a 
precipitate that was removed by filtration. The filtrate was evaporated to yield white 
waxy crystals that were purified by sublimation under vacuum to yield 120 mg (36% 
yield) of the pure product: mp 80-81OC; 1H NMR (CDC13) 6 3.77 (s, 9H); 6 9.25 (m, 
2H);6 9.69 (s, lH), 6 10.49 (m, 2H); high resolution mass spec (exact mass) : found 
195.1060, calc 195.1059. 
N-fert-5utyl-a-[4-[~~F]fluorophenyl)nitrne ([18F]FPSN) 
Method A. From N-fert-butyl-a-(4-nitrophenyl)nitrone (Fig. 2 (A)). The 
[18F]fluoride (typically 50 mCi)/K2CO3 solution was added to a solution of 26 mg 
4,7,13,16,21,24-hexaoxa-1 ,lO-diazabicyclo[8.8.8] hexacosane (Kryptofix 2.2.2) in 500 
PI CH3CN. The solution was evaporated at a temperature of 105OC under a 
continuous nitrogen stream (about 20 ml/min.). Residual water was removed by two 
additions of 1 ml anhydrous CH3CN and subsequent heating at 105OC under a flow of 
nitrogen. To the residue was added N-fert-butyl-a-(4-nitrophenyl)nitrone (8 mg) 
dissolved in 500 pl anhydrous DMSO and the vessel was sealed and heated at 130°C 
for 15 min, during which the color of the reaction mixture changed from yellow to dark 
green. The mixture was diluted with 7 ml H 2 0  and passed through an activated (2x5 
ml ethanol followed by 10 ml H 2 0 )  C18 Sep-Pak. The Sep-Pak was rinsed twice with 
5 ml H 2 0  and [IBFIFPBN was eluted with 5 ml ethanol. Radiochemical yields of 
3.0+0.3% (meanksd, n=3, decay corrected) were obtained in a total synthesis time of 
35 min. H P L C  analysis exhibited a single radioactive peak coeluting with authentic N- 
terf-butyl-a-(4-fluorophenyI)nitrone, and two chemical mass peaks corresponding to N- 
terf-butyl-a-(4-nitrophenyl)nitrone and N-tert-butyl-a-(4-fluorophenyl)nitrone. No 
attempts were made to separate these compounds. 
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Method B. From 4-[l8F]fluorobenzaldehyde (Fig. 2 (B)). The [18F]fluoride 
/K2CO3/ Kryptofix solution was dried by the procedure described above. After the 
drying step the nitrogen flow from the reactor was directed to a second reaction vial 
containing 10 mg N-tert-butyl hydroxylamine.HC1 in 1 ml 2N NaOH. 4-N,N,N- 
Trimethylammoniumbenzaldehyde triflate (8 mg) in 500 pI anhydrous DMSO was 
added to the dried [18F]fluoride/K+/Kryptofix mixture and was heated to 130OC for 15 
min. under a continuous nitrogen stream. The 4-[18F]fluorobenzaldehyde produced 
was continuously distilled into the N-tert-butylhydroxylamine solution. After 15 min, the 
nitrogen flow was stopped, and the [18F]fluorobenzaldehyde allowed to react with the 
hydroxylamine for an additional 10 min. at room temperature. 
The solution was then neutralized by addition of 1.2 ml 1M H3P04, diluted to 10 
ml with water and passed through an activated (2x5ml ethanol followed by 10 ml H20) 
C18L Sep-Pak (Waters) to separate [18F]FPBN from excess N-tert-butyl- 
hydroxylamine. The Sep-Pak was rinsed twice with 5 ml 0.5M NaH2P04 and once 
with 5 ml H20 to remove all hydroxylamine. [18F]FPBN was finally eluted from the 
Sep-Pak with 1.5 ml ethanol followed by 0.5 ml H20. A sample (10 PI) of this solution 
was injected on the HPLC to determine the specific activity. The concentration of N- 
tert-butylhydroxylamine in the ethanol eluate was below the detection limit (0.1 
pmol/mI) of TLC (MeOH HOAc 0.5%) with iodine vapor detection . The ethanolic 
solution was diluted to a total volume of 15 ml with saline and sterilized by filtration 
(Anotop 25, 0.2 pm Whatman). Radiochemical yields of 24~-10% (meanksd, n=3, 
decay corrected) were obtained in a total synthesis time of 45 min. HPLC analysis 
showed a single radioactive peak coeluting with authentic N-tert-butyl-a-(4- 
fluoropheny1)nitrone. The specific activity was 402+16 mCi/pmol (meanksd, n=3) at 
end of synthesis. 
RESULTS AND DISCUSSION 
A sample of authentic N-tert-butyl-a-(4-fluorophenyl)nitrone (FPBN) was 
synthesized by the procedure described by Angelini et al. (10) for the synthesis of 
[“%]PBN. Although the synthesis is a one-pot reaction, it involves two steps, the 
nucleophilic attack of the hydroxylamine nitrogen on the benzaldehyde carbonyl group 
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followed by proton migration and elimination of water. Fluorine-18 labeled FPBN can 
be prepared by the aromatic nucleophilic substitution by [I 8Flfluoride ion on the 
commercially available N-tert-butyl-a-(4-nitro-phenyl)nitrone (Fig. 2 (A)). The nitrone 
group is only moderately activating resulting in a low radiochemical yield (3%), and 
this synthesis method would require a final HPLC purification to separate [1*F]FPBN 
from the corresponding nitro-substituted nitrone. Better overall radiochemical yields of 
[ I  *F]FPBN are obtained by the two-step synthesis, involving the intermediate 
preparation of 4-[18F]fluorobenzaldehyde followed by reaction with N-tert- 
butylhydroxylamine (Fig. 2 (6)). 
4-[18F]Fluorobenzaldehyde is a commonly used intermediate and is prepared by the 
nucleophilic substitution by [18F]fluoride ion on 4-NO2-benzaldehyde or 4-N, N, N- 
trirnethylarnmoniumbenzaldehyde triflate. 
YH3 K2.2.2/K&0,/*8F CH3 
N O z e H = N - - C - - C H 3  - ''F+CH=N-(!+CH3 I I  (A) 
DMSO 130°C 0 CH3 I I  0 CH3 
K2.2.2/K2CD3/I8F 1 8  
CH3S-CHXI -
I DMSO 13OoC 
P 3  
Tf CH3 
I 
NaOH 2N HO-NH- -CHjHCI 1 kH3 
ig. 2 Synthesis of [18F]F-PBN from N02-PBN (A) and from 4-N,N.N-trirnethyl, 
ammoniurnbenzafdehyde-triflate (B). 
4-[18F]Fluorobenzaldehyde is then usually isolated from the labeling reaction mixture 
by solid phase extraction. We found that 4-[18F]fluorobenzaldehyde can be easily 
removed from the labeling reaction mixture by maintaining a nitrogen flow through the 
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reaction solution. In this way 4-[18F]fluorobenzaldehyde distills upon its formation 
together with some DMSO, the amount of which depends on the labeling temperature 
and the nitrogen flow. Analysis after heating at 130% for 10 min. under a continuous 
stream of nitrogen showed that more than 98% of total 4-[18F]fluorobenzaldehyde was 
distilled from the labeling reaction mixture together with about 300 pl of DMSO. Both 
the 4-N,N,N-trimethylammoniumbenzaldehyde triflate and the nitrobenzaldehyde are 
not volatile under these conditions and remain in the initial reaction vial obviating the 
necessity of an eventual HPLC purification to separate nitro- and fluorine-18 labeled 
nitrones. 
For the second step in formation of [18F]FPBN, the 4-[1*F]fluorobenzaldehyde is 
distilled into a vial where it is efficiently trapped (>95%) in a basic aqueous solution 
containing N-tert-butylhydroxylamine. The rate of conversion of the aldehyde to the 
nitrone is largely dependent on the concentration of NaOH. The conversion is virtually 
quantitative after 10 min. in 2N NaOH at room temperature. 
After completion of the condensation reaction, the reaction mixture is 
neutralized and excess N-tert-butylhydroxylamine, inorganic salts and DMSO are 
removed by Sep-Pak purification yielding pure [ISFIFPBN exhibiting an identical 
retention time on HPLC as the authentic cold FPBN. The radiochemical purity was 
better than 98% and [I8F]FPBN remains stable for more than 6 hours in a 10% ethanol 
solution in saline, as determined by HPLC. 
The overall yield of [I*F]FPBN is mainly dependent on the initial 
[18F]fluorobenzaldehyde formation, for which similar yields (12) have been reported in 
the literature (70% from resolubilized [18F]fluoride and 30-40% from total fluoride). 
The lower yields obtained here can probably be attributed to variability in reactivity of 
the [18F]fluoride ion used in this study, which is also reflected in the range of yields 
obtained. The specific activity of the [18F]FPBN appears to be low (about 400 
mCi/pmol) but is reasonable in view of the low amount of starting activity (50 mCi 
[18F]fluoride). 
In conclusion, we have synthesized [18F]FPBN by reacting N-tert- 
butylhydroxylamine with 4-[18F]fluorobenzaIdehyde, which was in turn obtained by 
d is t i I la t ion from a [ 1 8 F] f I u o r id e- 4 - N, N ,  N- t r im e t h y lam m o n i u m ben za Ide h y d e t r if I a t e 
reaction mixture. The final product was obtained in yields, chemical and 
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radiochemical purities, and specific activities sufficient for utilization in in vivo animal 
experiments. The results of these studies will be presented elsewhere. 
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